Blood-pressure reduction is the only proven treatment to prevent stroke. Whether a single pill that combines three ...

Idvynso is a new once-daily, two-drug oral regimen for adults with HIV-1 who are virologically suppressed and have no history ...

The change follows rising complaints about pharmacies refusing to cut tablet strips, forcing patients to buy extra medication. NEW DELHI: Patients may no longer be forced to buy an entire strip of ...

Much to the relief of the needle-shy, the Food and Drug Administration has just approved a second oral GLP-1 drug, following the release of the semaglutide Wegovy pill in January. But this new tablet, ...

We may receive a commission on purchases made from links. With the iPad, Apple has one of the most sought-after tablet lineups on the market, though in typical Apple fashion, a purchase can run much ...

Metformin has a strong claim to being one of the most influential medicines of the past century. For decades, it has ...

All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission. SEE ALSO: Live updates on ...

The drug, made by Eli Lilly, could offer a more convenient option for patients who want to avoid injections. By Dani Blum and Rebecca Robbins The Food and Drug Administration on Wednesday approved a ...

The U.S. Food and Drug Administration’s approval of Eli Lilly’s once-daily pill orforglipron as a weight loss and obesity treatment this week was the fastest approval of a new medication in decades.

The Food and Drug Administration on Wednesday approved a new weight loss pill from drugmaker Eli Lilly. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive ...

April 23 (Reuters) - Novo Nordisk's oral GLP-1 drug significantly lowered blood sugar levels in children and adolescents with ...

The FDA approved a GLP-1 pill from Eli Lilly called Foundayo. Foundayo isn't as effective as Lilly's weekly shot Zepbound, but the once-daily pill could be attractive for people looking for ...